Its announcement arrives to the heels of an analogous licensing arrangement provided in February to Adastra Labs, which had until eventually now centered on crafting cannabis extracts.But it really’s not very clear less than what conditions the companies will be able to market the medicine, and B.C. Leading David Eby reported he was “astonishe